The Institute for Personalized Medicine at Mount Sinai

Institute for Personalized Medicine at Mount Sinai Clinical
The Institute of Personalized Medicine at Mount Sinai Clinical
Oncology

T & B Cell Gene Rearrangements

  • Objective: To aid in the diagnosis of T and B cell lymphoproliferative disorders
  • Description: Detect gene rearrangements of the T-cell receptor Gamma (TRG), T-cell receptor Beta (TRB), B-cell immunoglobulin heavy chain (IGH), and B-cell immunoglobulin light chain kappa (IGK) genes to determine the clonality of T or B cells
  • Performing Lab: Molecular Pathology
    Direct inquiries to Dr. David Y. Zhang (212)-659-8173
  • Specimen requirements: One (1) lavender top (EDTA) tube (4ml) from peripheral blood or bone marrow aspirate or one (1) paraffin-embedded tissue block

JAK2 Mutation

  • Objective: To aid in the diagnosis of myeloproliferative disease.
  • Description: Detect a mutation in the Janus kinase 2 (JAK2) gene located in exon 14 (V617F) that has been associated with polycythemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF)
  • Performing Lab: Molecular Pathology
    Direct inquiries to Dr. David Y. Zhang (212)-659-8173
  • Specimen requirements: One (1) lavender top (EDTA) tube (4ml) from peripheral blood

bcr-abl

  • Objective: To therapeutically monitor patients with chronic myelogenous leukemia (CML)
  • Description: Quantitate bcr/abl fusion transcripts (b3a2, b2a2 and e1a2) caused by the t(9;22) translocation to assess therapy efficacy and monitor minimal residual disease
  • Performing Lab: Molecular Pathology
    Direct inquiries to Dr. David Y. Zhang (212-659-8173)
  • Specimen requirements: One (1) lavender top (EDTA) tube (4ml) from peripheral blood or bone marrow aspirate or one (1) paraffin-embedded tissue block

Conventional and Molecular Cytogenetics (FISH) Hematological Malignancies

  • Objective: To evaluate prognosis and aid in the selection of appropriate treatment in specific types of leukemia
  • Description: Examine specific chromosomal and/or gene abnormalities associated with specific types of leukemia
  • Performing Lab: Tumor Cytogenics
    Direct inquiries to Dr. Vesna Naifeld (212) 241-8801
  • Specimen requirements: Paraffin-embedded Brain Biopsy

Molecular Cytogenetics (FISH)

  • Objective: For evaluation of brain cancer, specifically glioma with favorable prognosis Description: Examine the presence of co-deletion of 1p and 19q in patients with glioma using four different chromosomal regions
  • Performing Lab: Tumor Cytogenetics
    Direct inquires to Dr. Vesna Najfeld (212) 241-8801
  • Specimen requirments: Paraffin-embedded Brain Biopsy
Mount Sinai School of Medicine
(800) MD-SINAI (800) 637-4624

Visit Mount Sinai Queens